鼻罩与口鼻罩对慢性高碳酸血症患者家庭无创通气的比较:系统评价与个体参与者数据荟萃分析
该个体参与者数据荟萃分析比较鼻罩与口鼻罩对COPD和肥胖低通气综合征(OHS)患者家庭无创通气疗效和依从性的影响。纳入8项RCT共290例个体数据,口鼻罩使用占86%。结果显示两种面罩在日间PaCO2、PaO2和无创通气依从性上均无差异,且基础疾病与面罩类型无交互作用。
要点
- 口鼻罩是OHS和COPD患者家庭无创通气最常用的接口。
- 鼻罩与口鼻罩在改善日间PaCO2、PaO2及依从性上无差异。
- 基础疾病(COPD或OHS)不影响面罩类型与结局的关系。
核心结论
- 口鼻罩是OHS和COPD患者家庭无创通气最常用的接口,但鼻罩与口鼻罩在疗效和耐受性上无差异。
研究设计与样本
- 系统评价与个体参与者数据荟萃分析,检索Medline和Cochrane Central Register of Controlled Trials,纳入1994年1月至2019年4月发表的疗程至少1个月的前瞻性随机对照试验(RCT)。
- 从1576篇文章中筛选出34项符合纳入标准的RCT,获得18项RCT的个体参与者数据(IPD)。
主要发现
- 口鼻罩使用比例为86%。
- 口鼻罩与鼻罩相比,日间PaCO2差异为0.61 mmHg(95%CI -2.15至3.38;p=0.68)。
- 口鼻罩与鼻罩相比,日间PaO2差异为-0.00 mmHg(95%CI -4.59至4.58;p=1)。
- 基础疾病与面罩类型对任何结局均无交互作用。
关键数值与推荐
- 纳入标准:评估OHS和COPD患者无创通气疗效的前瞻性RCT,疗程至少1个月,发表时间为1994年1月至2019年4月。
- 主要结局:日间PaCO2、PaO2和无创通气依从性。
- 排除标准:仅使用一种面罩类型或面罩数据缺失的RCT。
临床怎么用
- 在为OHS和COPD患者选择家庭无创通气接口时,鼻罩与口鼻罩在疗效和依从性上等效,可根据患者偏好和耐受性选择。
- 口鼻罩是临床最常用的接口,但鼻罩可作为替代选择,无需担心疗效或依从性差异。
局限性
- 仅纳入8项RCT共290例IPD,样本量有限。
- 口鼻罩使用比例高达86%,鼻罩数据相对较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal interface for the delivery of home non-invasive ventilation (NIV) to treat chronic respiratory failure has not yet been determined. The aim of this individual participant data (IPD) meta-analysis was to compare the effect of nasal and oronasal masks on treatment efficacy and adherence in patients with COPD and obesity hypoventilation syndrome (OHS). METHODS: We searched Medline and Cochrane Central Register of Controlled Trials for prospective randomised controlled trials (RCTs) of at least 1 month's duration, published between January 1994 and April 2019, that assessed NIV efficacy in patients with OHS and COPD. The main outcomes were diurnal PaCO2, PaO2 and NIV adherence (PROSPERO CRD42019132398). FINDINGS: Of 1576 articles identified, 34 RCTs met the inclusion criteria and IPD were obtained for 18. Ten RCTs were excluded because only one type of mask was used, or mask data were missing. Data from 8 RCTs, including 290 IPD, underwent meta-analysis. Oronasal masks were used in 86% of cases. There were no differences between oronasal and nasal masks for PaCO2 (0.61 mm Hg (95% CI -2.15 to 3.38); p=0.68), PaO2 (-0.00 mm Hg (95% CI -4.59 to 4.58); p=1) or NIV adherence (0·29 hour/day (95% CI -0.74 to 1.32); p=0.58). There was no interaction between the underlying pathology and the effect of mask type on any outcome. INTERPRETATION: Oronasal masks are the most used interface for the delivery of home NIV in patients with OHS and COPD; however, there is no difference in the efficacy or tolerance of oronasal or nasal masks.
引用
- Lebret M, Léotard A, Pépin JL, et al. Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis. Thorax. 2021. PMID: 33859049. doi:10.1136/thoraxjnl-2020-215613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。